Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.44B 5.05B 4.66B 8.78B 598B 8.94B 59.84B 23.43B 297B 23.53B 23.02B 999B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.29B 4.91B 4.53B 8.53B 581B 8.69B 58.16B 22.77B 289B 22.87B 22.37B 971B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +2.74% | ||
| 6 months | +64.84% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 02/02/26 | Free | Chief Financial Officer | 226,000 | 0.1691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +144.57% | +408.16% | 6.27B | |
| +0.42% | +4.34% | -0.03% | +13.18% | 49.37B | |
| -3.95% | +14.70% | +24.15% | +5.15% | 39.14B | |
| +6.22% | +1.81% | +419.17% | +647.45% | 40.85B | |
| -1.57% | -1.44% | +7.38% | +43.06% | 35.81B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 30.5B | |
| -0.39% | -0.63% | - | - | 16.55B | |
| -1.13% | -4.54% | +32.10% | +126.95% | 16.14B | |
| -7.10% | -2.81% | -8.80% | -34.35% | 12.77B | |
| -0.26% | +3.01% | +1.60% | +9.30% | 13.71B | |
| Average | -0.15% | +5.64% | +70.20% | +141.16% | 26.11B | |
| Weighted average by Cap. | +0.44% | +6.89% | +81.86% | +141.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.03 12.1 11.16 21.02 1.43K 21.4 143.24 56.08 711.22 56.33 55.1 2.39K |
| Net income | -236M -205M -190M -175M -330M -22.51B -336M -2.25B -881M -11.18B -885M -866M -37.59B | -198M -172M -159M -147M -277M -18.86B -282M -1.89B -739M -9.37B -742M -726M -31.5B |
| Net Debt | -364M -316M -294M -271M -511M -34.78B -520M -3.48B -1.36B -17.28B -1.37B -1.34B -58.1B | -176M -153M -142M -131M -247M -16.82B -251M -1.68B -659M -8.35B -662M -647M -28.1B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
